These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 39183090)

  • 21. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD007807. PubMed ID: 32851663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.
    Gontero P; Birtle A; Capoun O; Compérat E; Dominguez-Escrig JL; Liedberg F; Mariappan P; Masson-Lecomte A; Mostafid HA; Pradere B; Rai BP; van Rhijn BWG; Seisen T; Shariat SF; Soria F; Soukup V; Wood R; Xylinas EN
    Eur Urol; 2024 Dec; 86(6):531-549. PubMed ID: 39155194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
    Jonker D; Rumble RB; Maroun J;
    Curr Oncol; 2006 Oct; 13(5):173-84. PubMed ID: 22792014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration.
    Soria F; Rosazza M; Livoti S; Moschini M; De Angelis M; Giudice FD; Pichler R; Hurle R; Mancon S; Carrion DM; Krajewski W; Mertens LS; D'Andrea D; Mari A; Di Maida F; Dutto D; Colucci F; Casale G; Fertitta G; Laukhtina E; Albisinni S; Pradere B; Teoh JYC; Shariat SF; Briganti A; Kamat AM; Gontero P
    Eur Urol Oncol; 2024 Dec; 7(6):1497-1503. PubMed ID: 38906794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results.
    Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I
    Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications.
    Jeong MS; Baek SW; Yang GE; Mun JY; Kim JA; Kim TN; Nam JK; Choi YH; Lee JS; Chu IS; Leem SH
    Cancer Lett; 2025 Feb; 610():217339. PubMed ID: 39608442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysis.
    Roh ME; Gutman J; Murphy M; Hill J; Madanitsa M; Kakuru A; Barsosio HC; Kariuki S; Lusingu JPA; Mosha F; Kajubi R; Kamya MR; Mathanga D; Chinkhumba J; Laufer MK; Mlugu E; Kamuhabwa AAR; Aklillu E; Minzi O; Okoro RN; Geidam AD; Ohieku JD; Desai M; Jagannathan P; Dorsey G; Ter Kuile FO
    medRxiv; 2024 Nov; ():. PubMed ID: 39649586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for people with perceptual disorders after stroke: the PIONEER scoping review, Cochrane systematic review and priority setting project.
    Hazelton C; Todhunter-Brown A; Campbell P; Thomson K; Nicolson DJ; McGill K; Chung CS; Dorris L; Gillespie DC; Hunter SM; Williams LJ; Brady MC
    Health Technol Assess; 2024 Oct; 28(69):1-141. PubMed ID: 39485540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel intravesical therapies and delivery systems for the management of bladder cancer.
    Grobet-Jeandin E; Rouprêt M; Seisen T
    Curr Opin Urol; 2025 Jan; 35(1):19-27. PubMed ID: 39376040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.
    Todhunter-Brown A; Booth L; Campbell P; Cheer B; Cowie J; Elders A; Hagen S; Jankulak K; Mason H; Millington C; Ogden M; Paterson C; Richardson D; Smith D; Sutcliffe J; Thomson K; Torrens C; McClurg D
    Health Technol Assess; 2024 Jan; 28(5):1-266. PubMed ID: 38343084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives.
    Baker RR; Pereira da Silva JR; Smith G
    Food Chem Toxicol; 2004; 42 Suppl():S3-37. PubMed ID: 15072836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY; Lenza M; Tamaoki MJ; Faloppa F; Belloti JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010071. PubMed ID: 24782334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT.
    Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C
    Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.